A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury-Reference-Cited by-同舟云学术

A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury

Published:2012-03-23 Issue:8 Volume:165 Page:2462-2478
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Horváth Bėla,Magid Lital,Mukhopadhyay Partha,Bátkai Sándor,Rajesh Mohanraj,Park Ogyi,Tanchian Galin,Gao Rachel Y,Goodfellow Catherine E,Glass Michelle,Mechoulam Raphael,Pacher Pál

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.2011.01381.x/fullpdf

Reference39 articles.

1. Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo;Abe;Free Radic Biol Med,2009

2. Guide to Receptors and Channels (GRAC), 5th Edition;Alexander;Br J Pharmacol,2011

3. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury;Batkai;FASEB J,2007

4. Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia;Caraceni;Gut,2009

5. Targeting the endocannabinoid system: to enhance or reduce?;Di Marzo;Nat Rev Drug Discov,2008

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid Receptor-2 agonist AM1241 Attenuates Myocardial Ischemia-Reperfusion-Induced Oxidative Stress in Rats via Nrf2/HO-1 Pathway;Medical Principles and Practice;2024-08-12

2. The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update;Molecules;2024-07-18

3. RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models;Frontiers in Pharmacology;2024-07-12

4. A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies;ACS Pharmacology & Translational Science;2024-07-09

5. Patent review of cannabinoid receptor type 2 (CB ₂ R) modulators (2016-present);Expert Opinion on Therapeutic Patents;2024-07-02